Bowers Lisa 4
4 · DICE Therapeutics, Inc. · Filed Apr 1, 2022
Insider Transaction Report
Form 4
Bowers Lisa
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-31+42,500→ 42,500 totalExercise: $19.13Exp: 2032-03-31→ Common Stock (42,500 underlying)
Footnotes (1)
- [F1]The option vests as to 1/36th of the total shares on each monthly anniversary of March 31, 2022, subject to the Reporting Holder's continued service to the Registrant.